Cited by 1,425Computational Drug Discovery MethodsReceptor Mechanisms and Signalingvaccines and immunoinformatics approaches

Virtual screening of chemical libraries

Open access
Shoichet, Brian K.·2004·Nature

Abstract

Virtual screening uses computer-based methods to discover new ligands on the basis of biological structures. Although widely heralded in the 1970s and 1980s, the technique has since struggled to meet its initial promise, and drug discovery remains dominated by empirical screening. Recent successes in predicting new ligands and their receptor-bound structures, and better rates of ligand discovery compared to empirical screening, have re-ignited interest in virtual screening, which is now widely used in drug discovery, albeit on a more limited scale than empirical screening.

Integrity signals

Registry

Crossref · 10.1038/nature03197

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Accurate prediction of the biochemical properties of small molecules can significantly accelerate drug discovery by reducing the need for expensive lab experiments.

    “Accurate prediction of the biochemical properties of small molecules can significantly accelerate drug discovery by reducing the need for expensive lab experiments (Shoichet, 2004; Hughes et al., 2011).”

    From WILDS: A Benchmark of in-the-Wild Distribution Shifts (2020) · cites this paper as Shoichet, 2004

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shoichet, B. K.
Affiliations
University of California, San Francisco (US)
Corresponding author
Shoichet, Brian K.
Venue
Nature
Published
2004-12
Volume
432
Issue
7019
Pages
862-865
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2074978477
Cited by
1,425
References
3
Citations by year
2026: 83 · 2025: 76 · 2024: 73 · 2023: 74 · 2022: 75 · 2021: 76 · 2020: 88 · 2019: 70 · 2018: 80 · 2017: 63 · 2016: 58 · 2015: 56 · 2014: 53 · 2013: 57 · 2012: 72
FWCI
3.19
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
National Institute of General Medical Sciences (R01GM059957)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
virtual screening, chemical libraries, ligand discovery, drug discovery, structure-based drug design
MeSH terms
Computer Simulation, Drug Evaluation, Preclinical, Pharmaceutical Preparations, Ligands, Models, Molecular, Molecular Conformation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review